Real stories that help make ADHD more

relatable

Bennett & Ann

Real patient stories

Watch the videos below to see Bennett, Emmett, and Eli’s real ADHD stories, and how—with the help of their moms—they were able to help manage their ADHD symptoms with non-stimulant Qelbree.

Bennett & Ann

"He's still himself, but a manageable self"

– Ann, Bennett's mom

When 9-year-old Bennett's ADHD symptoms started getting in the way of his school and social life, he and his mom, Ann, knew it was time for a change. Hear their story and how Qelbree helps manage Bennett's ADHD symptoms today.

Emmett & Cyrena

"I definitely didn't think I would get to this place"

– Emmett, Qelbree Patient

13-year-old Emmett had tried stimulants for ADHD in the past, but they weren’t the right fit. Hear how his mom, Cyrena, discovered non-stimulant Qelbree and how Emmett’s ADHD symptoms have improved since.

Eli & Laura

"Since I was diagnosed, I feel like I've been listened to"

– Eli, Qelbree patient

At the beginning of the COVID pandemic, online schooling shined a new light on 9-year-old Eli's ADHD symptoms. Hear from Eli and his mom, Laura, on how pivotal it was to get an official ADHD diagnosis and how Qelbree helps manage Eli's symptoms today.

A change you can see

Qelbree is the first non-stimulant approved for ADHD in over a decade.

See the results

Stay in the know

Join Qelbree Insider to receive Qelbree updates, personalized tips for supporting your child with ADHD, and other helpful resources for you and your child.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.